Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Statements

Latest Statements

Rio de Janeiro - Praça da Cruz Vermelha activity Photograph by Mariana Abdalla
Statement
Statement |
16 July 2024
Pandemic preparedness

Pandemic Agreement: MSF Statement at INB10

2 min
Report cover image
Statement |
15 May 2024
Antimicrobial resistance

MSF statement and position paper on UNHLM for AMR

The MSF team prepare medical supplies to transport by motor boat to isolated communities in Delta Amacuro state, northeastern Venezuela. Photo credit: Matias Delacroix
Statement
Statement |
18 March 2024
Pandemic preparedness

Pandemic Agreement: MSF statement on revised draft of negotiating text

2 min
Round of medical staff in the Covid-19 patients ward, Yaoundé, Cameroon. Photo credit: MSF/Vanessa Fodjo
Statement
Statement |
18 February 2024
Pandemic preparedness Intellectual property and trade

Pandemic Accord: MSF statement at INB8 plenary session

2 min
Goma, North Kivu province in the Democratic Republic of Congo (DRC), multi-antigen vaccination campaign. Photo credit: MSF/Alexandre Marcou
Statement
Statement |
22 January 2024
Vaccines

MSF statement on EB 154/9 - Immunization Agenda 2030

2 min
MSF Medical Doctor Ramya, conducting physical examination of female DRTB patient during her follow-up visit to endTB clinic. Photo credit: Siddharth Singh
Statement
Statement |
22 January 2024
Tuberculosis

MSF statement on EB154/10 - End TB Strategy

2 min
Yusufa Adam, 5 years, received treatment for noma in the Sokoto hospital. Photograph by Ghada Safaan
Statement
Statement |
22 January 2024
Tropical & neglected diseases

MSF statement on EB 154/11 - Road map for neglected tropical diseases 2021-2030

1 min
Antimicrobial resistance (AMR) is a major public health threat. Low- and middle-income countries are often hit the hardest. Photo credit: MSF/SORIYA
Statement
Statement |
22 January 2024
Antimicrobial resistance

MSF statement on EB 154/13 - Antimicrobial resistance (AMR): accelerating national and global responses

1 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury